374 filings
Page 5 of 19
6-K
kn0 lnri1
13 Oct 22
Pfizer and BioNTech Announce Positive Early Data From Clinical Trial of Omicron BA.4/BA.5-Adapted Bivalent Booster in Individuals 18 Years and Older
5:58pm
6-K
u543241gq nxt
12 Oct 22
Current report (foreign)
5:17pm
6-K
vpz3dj
26 Sep 22
Current report (foreign)
7:18am
6-K
6oumgtbe awe
16 Sep 22
Current report (foreign)
4:20pm
6-K
s7d9oomh
12 Sep 22
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster in European Union
4:13pm
6-K
aikygc 4ue1
9 Sep 22
BioNTech Presents Encouraging Phase 1/2 Follow-up Data for CAR-T Candidate BNT211 in Hard-To-Treat Solid Tumors at ESMO
4:41pm
6-K
fbcisgyrio4a 8bjur
7 Sep 22
BioNTech CEO Ugur Sahin Visited Israel to Discuss Cooperation on Pandemic Preparedness and the Development of Innovative Medicines
6:56am
6-K
6zze8b4yid3a3wp08
2 Sep 22
Current report (foreign)
9:15am
6-K
2rudklsj
1 Sep 22
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.1-Adapted Bivalent COVID-19 Vaccine Booster in European Union
5:38pm
6-K
x8oi 1ze35c4w
31 Aug 22
Current report (foreign)
5:08pm
6-K
ouuz2lmz
26 Aug 22
Statement on Patent Infringement Lawsuit Filed by Moderna
5:02pm
6-K
e4862j3c0mgnu
26 Aug 22
Pfizer and BioNTech Complete Submission to European Medicines Agency for Omicron BA.4/BA.5 Adapted Bivalent Vaccine
4:53pm
6-K
vgkkxrumictfdj0m8
23 Aug 22
Pfizer and BioNTech Announce Updated COVID-19 Vaccine Data Supporting Efficacy in Children 6 Months through 4 Years of Age
8:56am
6-K
pcd2lhadjwu7cpd66vh5
22 Aug 22
Current report (foreign)
5:23pm
6-K
aw2o9g
8 Aug 22
Unaudited Interim Condensed Consolidated Financial Statements
7:17am
6-K
onytn31az50w
8 Aug 22
BioNTech Announces Second Quarter Financial Results and Corporate Update
7:16am
6-K
zb3rgsvrtprywom5so7t
5 Aug 22
BioNTech and Genmab Expand Global Strategic Collaboration to Develop and Commercialize Novel Immunotherapy Candidates
6:49am
6-K
9y4bzc0i3j uo5
27 Jul 22
Pfizer and BioNTech Advance COVID-19 Vaccine Strategy With Study Start of Next-Generation Vaccine Candidate Based on Enhanced Spike Protein Design
6:55am
6-K
v37931nj55i
25 Jul 22
Current report (foreign)
5:59pm
6-K
4pt 3p56eacm88
19 Jul 22
Pfizer and BioNTech Complete Submission to European Medicines Agency for Omicron BA.1 Adapted Bivalent Vaccine Candidate
5:12pm